Literature DB >> 27008307

The Treatment of Chronic Neuropathic Pain: Bio (Regenerative) Pain Treatment through Lipofilling. A Short Communication Case Series.

Haico de Gast1, Bart Torrensma1, Eillis Fitzgerald1, Hieronymus Stevens1.   

Abstract

The following case series describes the treatment of neuropathic pain in post-surgical scars, using adipocytes and adipose-derived stem/progenitor cells (ASCs). Two cases are described in which patients underwent lipofilling to treat painful scars after cosmetic surgery. The primary indication for lipofilling was pain reduction and not improved cosmesis. Numeric rating scale (NRS) values were reported before the intervention and at regular intervals after the lipofilling. We found a notable long-lasting reduction in the NRS values after the "modified" lipofilling treatment. The results are promising and reinforce earlier data on the positive effect of lipofilling and pain in scars.

Entities:  

Mesh:

Year:  2016        PMID: 27008307

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  3 in total

1.  Autologous Fat Transfer as a Treatment for Peripheral Neuropathic Pain without Apparent Cause.

Authors:  Jip Beugels; Juliette E Hommes; Andrea J R Balthasar; René R W J van der Hulst; Andrzej A Piatkowski de Grzymala
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-08-16

2.  The Role of Fat Grafting in Alleviating Neuropathic Pain: A Critical Review of the Literature.

Authors:  Mario Alessandri-Bonetti; Francesco M Egro; Paolo Persichetti; Sydney R Coleman; J Peter Rubin
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-05-21

3.  Fibroblast Growth Factor 1 Gene-Transfected Adipose-Derived Mesenchymal Stem Cells Modulate Apoptosis And Inflammation In The Chronic Constriction Injury Model of Neuropathic Pain.

Authors:  Fatemeh Forouzanfar; Hamid R Sadeghnia; Seyed Javad Hoseini; Ahmad Ghorbani; Hamed Ghazavi; Faezeh Ghasemi; Hossein Hosseinzadeh
Journal:  Iran J Pharm Res       Date:  2020       Impact factor: 1.696

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.